T1	Participants 212 265	critically ill neonates during the first week of life
T2	Participants 285 442	200 neonates (gestational ages 26.4-41 weeks) treated with netilmicin (4-5 mg/kg in extended dosing intervals) for postnatal sepsis in the first week of life
T3	Participants 831 864	critically ill neonates >32 weeks
T4	Participants 959 977	neonates <32 weeks
